Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission - Wikidata - thesis-toulmin - TriplyDB

Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission

Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission

http://www.wikidata.org/entity/Q28290182

about

A phase 2 study of vorinostat in acute myeloid leukemia Lifetime probabilities of hematopoietic stem cell transplantation in the U.S Risk factors for relapse after allogeneic transplantation in acute myeloid leukemia Allogeneic stem cell transplantation in first complete remission Progress in acute myeloid leukemia Interpreting outcome data in hematological malignancies: a paradigm for clinical studies Interpreting outcome data in hematopoietic cell transplantation for leukemia: tackling common biases.Long-term survival data from a phase 3 study of Filgrastim as an adjunct to chemotherapy in adults with de novo acute myeloid leukemia.Characterization of hemopoietic engraftment kinetics and development of secondary cytopenia in AML post auto-SCT and its correlation with survival outcome.A history of haemopoietic cell transplantation.Unrelated donor transplantation for acute myelogenous leukemia in first remission Targeting of a developmentally regulated epitope of CD43 for the treatment of acute leukemia.Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.Acute myeloid leukemia of donor origin after allogeneic stem cell transplantation from a sibling who harbors germline XPD and XRCC3 homozygous polymorphisms.Hematopoietic stem cell transplantation for leukemia Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: Blood A phase 1 dose-escalation study of ARRY-520, a kinesin spindle protein inhibitor, in patients with advanced myeloid leukemias Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia.High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CR.High-dose cytarabine in acute myeloid leukemia treatment: a systematic review and meta-analysis.Unrelated donor hematopoietic transplantation.The role of bone marrow transplantation in acute promyelocytic leukemia.Therapeutic options for acute myelogenous leukemia.The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial.Use of marine toxins in combination with cytotoxic drugs for induction of apoptosis in acute myelogenous leukaemia cells.Age and acute myeloid leukemia.HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemia.Radioimmunotherapy for acute leukemia.Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission.Acute myeloblastic leukaemias in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Acute myeloid leukemia: treatment of adults under 60 years.Acute myeloid leukemia: treatment over 60.Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?--an adult treater's view.Acute myeloid leukemia in children: a review of risk factors and recent trials.Clofarabine for the treatment of adult acute myeloid leukemia.Autologous transplantation gives encouraging results for young adults with favorable-risk acute myeloid leukemia, but is not improved with gemtuzumab ozogamicin Serum peptidomic profiling identifies a minimal residual disease detection and prognostic biomarker for patients with acute leukemia.Younger adults with acute myeloid leukemia in remission for ≥ 3 years have a high likelihood of cure: The ECOG experience in over 1200 patients.Autologous stem cell transplantation for acute myeloid leukemia.

P2860

Q24643266-239A4DC0-149F-4594-A079-D9254E638119 Q24653888-41BAEE6D-A5CB-424F-88FE-8C542C2CAAC6 Q26771438-ABCBD080-AF0D-4589-8039-4BE5405CDC9F Q26996818-125BB86D-E1BE-4F67-949F-01DDAB2D6B10 Q27024006-BED7CA73-2CC2-47D3-A5E7-7619F0A18BCC Q30658847-74FA23FF-8EBD-41BF-8C33-791CDC69EB72 Q30884173-316DBBA0-512F-4C59-A6A6-84E22D6625BD Q31030133-36FA904A-3807-49D4-B54B-15CA50928BB0 Q33383210-175A3620-01F1-4670-AD34-20DD2F436761 Q33610841-256D8146-4606-41AC-8C49-ED5F196E4B7D Q33841417-5D6E1ADB-44C2-491C-AD6F-8399619483BE Q33944427-FB0989F6-82FA-49B0-8AE2-BDCB17514099 Q33978951-2BC345A2-226A-41F9-BE44-155B9FB5EC30 Q34032840-A9A18A6C-4D4A-4B81-8F29-FF83570009A0 Q34034180-75914A17-5C33-4477-97E8-8BE974EC40DB Q34217884-77321C7B-48A2-491F-B4F5-4229DDE199B6 Q34238046-9CAC5990-BADF-4EE7-92BD-FB8833A6EF61 Q34268110-6AEDE5AA-7526-4B45-8A52-EB8A5E6D65F3 Q34297698-757DAC5D-320A-415F-B94E-579528C078A4 Q34317679-11005465-17C2-4539-AC78-D0CE7987C8F1 Q34326698-FE54517F-7EB1-4703-9D89-D4F319860302 Q34355952-C86896F3-0466-4BFF-B215-4D83E581BCC4 Q34380840-4EBC4E26-CFB3-4CFC-AF08-1C9AB4A7726A Q34525604-525C4C86-A9D4-4D13-A90B-4C79F3BF3C46 Q34534299-204A8B6E-2554-4E3F-A7B3-9C827AAD6B2A Q34564663-D13169F9-C01F-4372-B8A8-77078382A508 Q34572795-DA7F29E2-B2F4-499E-BFDC-0DAC47E2AE87 Q34608650-382D242B-28A2-42FB-90BB-9C13378CC9A3 Q34630588-81B01E7F-B1B6-4C31-A807-6BDC78B6CF66 Q34655572-CADD4BC9-59A8-4FC9-80BB-C01B0575AEF7 Q34680933-2F056A7E-385D-4F29-96A6-C495484AE1E9 Q34680938-5867A5F0-5D1D-4A45-A052-9E36E8243AF1 Q34720554-9BC7B26A-2C42-4F82-B03F-EC41665569D4 Q34760577-501F8402-CB00-4BC3-B404-4E455321A8A1 Q35008310-E1BD4CA5-C3A5-4ED5-B13F-F8DAEE7A22CF Q35009273-935481CF-4F02-4BD1-8DE8-45796E7EA830 Q35029920-FA3148C3-64B4-4498-8E42-9608D49B61BD Q35030141-CBA840C6-D13F-4DE5-A103-DA9C9660BA7A Q35077929-BC84C5D7-F1E6-4E9C-9141-D7293FFF35B7 Q35122189-8F48B9D3-2A19-4642-B61C-7481114B585E

P2860

Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission

http://www.wikidata.org/entity/Q28290182

description

1998 nî lūn-bûn

@nan

1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Chemotherapy compared with aut ...... id leukemia in first remission

@ast

Chemotherapy compared with aut ...... id leukemia in first remission

@en

Chemotherapy compared with aut ...... id leukemia in first remission

@nl

type

label

Chemotherapy compared with aut ...... id leukemia in first remission

@ast

Chemotherapy compared with aut ...... id leukemia in first remission

@en

Chemotherapy compared with aut ...... id leukemia in first remission

@nl

prefLabel

Chemotherapy compared with aut ...... id leukemia in first remission

@ast

Chemotherapy compared with aut ...... id leukemia in first remission

@en

Chemotherapy compared with aut ...... id leukemia in first remission

@nl

P1433

Q28290182-7ABBD7AB-577A-4728-83E0-5A5D234E59AC

P1476

Q28290182-2CFD9694-1294-481A-B3B8-95C921EFAA53

P2093

Q28290182-310548C3-DFAC-42F3-9748-8663C86F69A6

Q28290182-35B217EC-D11D-4545-831D-9F82CB46A055

Q28290182-37FF26F2-5FB3-4C4D-AECD-A1796BB5BAD8

Q28290182-45BB3BAF-D16E-49D3-B260-7F38CAFE9A6C

Q28290182-4DF3036B-66AE-412A-8D62-AB98B7FCB8AE

Q28290182-71F2F28A-ED21-4954-8EC5-5247597B6ABB

Q28290182-80D839EE-E614-4B18-8A38-21A41314EDD2

Q28290182-8532F0AD-C1C1-45D9-AB57-DC4D9CBC6AA1

Q28290182-9F018D14-E425-4AA4-BAFE-FC99260EC076

Q28290182-ADEE11AE-8F26-479C-95C5-0DCD21845405

P304

Q28290182-222A0C3E-EADD-4E4C-9EBD-B01E1961A247

P31

Q28290182-7F8AAEA1-4598-4BBA-BC8B-9AA103904A15

P3181

Q28290182-4D344828-57CA-4498-AAFA-5D75EEB3D89C

P356

Q28290182-7ED7BE6B-C80E-4BB0-9CF5-4619660F5D85

P407

Q28290182-1C36757E-4E80-45E9-ABD9-EFA791AF0F56

P433

Q28290182-F86EB01F-0CF2-4509-B31F-240158E3952A

P478

Q28290182-9ADBE1A9-7E7A-491D-AA1A-18CB63114A50

P50

Q28290182-8E137A89-CA04-49F5-BA1D-C1FD39CB108C

P577

Q28290182-781E3342-CA4C-4C64-9C13-99CC954E868D

P698

Q28290182-34CCF920-0612-4E9B-A4FD-12F6D981E5A2

P921

Q28290182-0BEB3820-7B62-4236-AE4B-538A47DF865A

Q28290182-68DDDE6F-C2B0-4CDF-A314-C4908EE7DCD2

Q28290182-C2E9014F-B694-4F01-BBFC-9969AA36302A

P3181

P356

NEJM199812033392301

P1433

The New England Journal of Medicine

P1476

Chemotherapy compared with aut ...... id leukemia in first remission

@en

P2093

C Willman

http://www.w3.org/2001/XMLSchema#string

D D Hurd

http://www.w3.org/2001/XMLSchema#string

D P Harrington

http://www.w3.org/2001/XMLSchema#string

D R Head

http://www.w3.org/2001/XMLSchema#string

E Paietta

http://www.w3.org/2001/XMLSchema#string

H M Lazarus

http://www.w3.org/2001/XMLSchema#string

J M Bennett

http://www.w3.org/2001/XMLSchema#string

J M Rowe

http://www.w3.org/2001/XMLSchema#string

K G Blume

http://www.w3.org/2001/XMLSchema#string

P A Cassileth

http://www.w3.org/2001/XMLSchema#string

P304

1649-56

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3698398

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJM199812033392301

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

339

http://www.w3.org/2001/XMLSchema#string

P50

Frederick R. Appelbaum

P577

1998-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9834301

http://www.w3.org/2001/XMLSchema#string

P921